Repeated Oscillatory TMS Therapy of the Epileptogenic Cortical Area in Children With Focal CSWS

Description

The investigators are investigating the effectiveness of a wearable multisite transcranial magnetic stimulation (mTMS) device that can deliver stimuli at multiple cortical sites simultaneously or sequentially for the treatment of an epileptic syndrome - focal continuous-spike and wave during sleep.

Conditions

CSWS

Talk to us

Study Overview

On this page

Study Details

Study overview

The investigators are investigating the effectiveness of a wearable multisite transcranial magnetic stimulation (mTMS) device that can deliver stimuli at multiple cortical sites simultaneously or sequentially for the treatment of an epileptic syndrome - focal continuous-spike and wave during sleep.

Repeated Oscillatory Transcranial Magnetic Stimulation Therapy of the Epileptogenic Cortical Area in Children With Focal Continuous-Spike and Wave During Sleep

Repeated Oscillatory TMS Therapy of the Epileptogenic Cortical Area in Children With Focal CSWS

Condition
CSWS
Intervention / Treatment

-

Contacts and Locations

Overland Park

Children's Mercy Hospital, Overland Park, Kansas, United States, 66211

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients between the ages of 3 and 21 years old,
  • * An electroclinical diagnosis of focal CSWS as defined by ILAE
  • * SWI of ≥ 85% in sleep on EEG's performed on previous or most recent EEG study.
  • * No change in antiepileptic drugs (AED) in last 2 week, or patients not on any AED
  • * Presence of metal implants or metallic devices in the head
  • * Any history of drug or alcohol abuse
  • * Presence of cardiac pacemaker
  • * Generalized CSWS
  • * Adults unable to consent
  • * Pregnant women
  • * Prisoners
  • * Wards of the state
  • * Non English speaking subjects and families

Ages Eligible for Study

3 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Children's Mercy Hospital Kansas City,

Lalit Bansal, M.D., PRINCIPAL_INVESTIGATOR, Children's Mercy Hospital Kansas City

Study Record Dates

2025-07-31